Webcast Alert: Tapestry Pharmaceuticals, Inc. Presentation at Informed Investors Biotechnology / Cancer On-line Investor Forum webcast on Thursday, October 6, 2005, 10:00 am ET

Business Wire, Oct 4, 2005

BOULDER, Colo. -- Tapestry Pharmaceuticals, Inc. (NASDAQ: TPPH) will present at the following forum:

What: Tapestry Pharmaceuticals, Inc. (NasdaqNM: TPPH) will give a presentation at Informed Investors Biotechnology / Cancer On-line Investors Forum.

When: October 6, 2005 @10:00 AM Eastern Time

Where: http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=89498

How: Live over the Internet--Simply log on to the web at the address above.

Contact: Gordon Link, Chief Financial Officer, glink@tapestrypharma.com , (303)516-8500

If you are unable to attend the live event, the forum will be archived and available via the Informed Investors website at http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=89498

Tapestry Pharmaceuticals, Inc. is a company focused on developing proprietary therapies for the treatment of cancer. The Company is also actively engaged in evaluating new therapeutic agents and related technologies for in-licensing.

Tapestry's technical expertise is based upon its ability to identify, chemically alter and produce novel therapeutic compounds derived from natural product sources.

Tapestry has developed a novel third generation taxane, TPI 287. In December 2004 the Company filed an IND application, and on January 21, 2005, it was cleared to proceed with clinical trials by the FDA. In May, 2005 its first TPI 287 Phase I study began.